Integrated multi-omic profiling enables recurrence risk stratification beyond pathological stage in resected EGFR-mutant lung adenocarcinoma

Study limitation reported by the research below: “The study is retrospective; prospective validation in larger, diverse cohorts is explicitly required before clinical implementation.”